Harlan Weisman - Chief Executive Officer @ TFF Pharmaceuticals

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title Chief Executive Officer
Primary Organization
TFF Pharmaceuticals

Location New Hope, Pennsylvania, United States
Regions Greater Philadelphia Area, Great Lakes, Northeastern US
Gender Male

Facebook View on Facebook
LinkedIn View on LinkedIn
X (Twitter) View on X

Harlan Weisman is the Chief Executive Officer of TFF Pharmaceuticals. He previously worked at Flame Biosciences as a Chairman, Co-Founder, CEO and President. Harlan Weisman attended the University of Maryland.

Jobs

Number of Current Jobs

Number of Past Jobs

Harlan Weisman

has

current jobs including

Chief Executive Officer

TFF Pharmaceuticals

Managing Director

And-One Consulting

, and

Operating Partner

CRG

. Additionally,

Harlan Weisman

has had

past jobs including

Vice Chairman, Interim President & CEO

TFF Pharmaceuticals

TFF Pharmaceuticals Chief Executive OfficerFeb 2023
And-One Consulting Managing DirectorMar 2012
CRG Operating Partner2012
American College of Cardiology Fellow
MycroFriends Co-Founder and Chief Scientific Officer
American Heart Association Fellow
American College Of Chest Physicians Fellow

Organization Name	Title At Company	Start Date	End Date
TFF Pharmaceuticals	Vice Chairman, Interim President & CEO	Sep 2018	2023
Flame Biosciences	Co-Founder, President, and CEO	Nov 2019	Jan 2022
Mycrobiomics	Co-Founder & Chief Scientific Stock Officer	2015	Dec 2018
Janssen Belgium	President of R&D	—	—
The Johns Hopkins University	Cardiovascular Disease Fellow	—	—
Johns Hopkins University School of Medicine	Assistant Professor of Medicine	—	—
And-One Consulting	Founder	—	—
Johnson & Johnson	Chief Science & Technology Officer of Medical Devices & Diagnostics	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Harlan Weisman

holds

board and advisor roles as

Venture Advisor

Israel Biotech Fund

and

Member of the Board of Governors

Patient-Centered Outcomes Research Institute

Israel Biotech Fund Venture AdvisorOct 2016
Patient-Centered Outcomes Research Institute Member of the Board of Governors

Organization Name	Title At Company	Start Date	End Date
Mycrobiomics	Member of the Board of Directors	—	—
J&J Development	Member of the Board of Directors	—	—
BioMotiv	Member of the Board of Advisors	—	—
Janssen Belgium	Chairman of the Board of Directors	—	—
ControlRad	Member of the Board of Directors	—	—
Experimental Pathology Laboratorie	Member of the Board of Directors	—	—
Hutchison Biofilm Medical Solutions	Member of the Board of Directors	—	—

Related Hubs

Hub Name	CB Rank (Hub)
Biopharma Companies that Exited	12,207
Pharmaceutical Companies that Exited	5,140
Companies That Exited in 2019 (Top 10K)	753
National Institute of Allergy and Infectious Diseases Portfolio Companies	87,000
Closed Biopharma Companies	37,891
Closed United States Pharmaceutical Companies	20,889
Closed United States Biotechnology Companies	8,128
Companies that Went Public in 2019	37,787
Closed Pharmaceutical Companies	21,883
Closed Biotechnology Companies	9,202